stockrowLeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- −14.3%
- Free cash flow
- −25.8%
- Total debt
- +0.53%
Quarter to September 2026, against a year earlier
Follow LMAT
Alert me
LeMaitre Vascular, Inc. (LMAT) Net income
LeMaitre Vascular, Inc.'s net income for fiscal 2025 was $57.7M, up 31.1% from $44.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $63.3M. Over the past ten years it has ranged from $7.8M (fiscal 2015) to $57.7M (fiscal 2025) — the current reading is the highest in ten years. Net income has risen for 3 consecutive fiscal years. LeMaitre Vascular, Inc. ranks 16th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $57.7M | 31.10% |
| FY2024 | $44.0M | 46.28% |
| FY2023 | $30.1M | 45.89% |
| FY2022 | $20.6M | (23.31%) |
| FY2021 | $26.9M | 26.80% |
| FY2020 | $21.2M | 18.32% |
| FY2019 | $17.9M | (21.83%) |
| FY2018 | $22.9M | 33.57% |
| FY2017 | $17.2M | 62.20% |
| FY2016 | $10.6M | 36.50% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $15.0M | (11.88%) |
| Jun 2026 | $17.1M | 8.74% |
| Mar 2026 | $15.7M | 0.62% |
| Dec 2025 | $15.6M | (10.25%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| STVN Stevanato Group S.p.A. compare | $227.4M |
| LMAT LeMaitre Vascular, Inc. | $63.3M |
| ATRC AtriCure, Inc. compare | $14.9M |
| WRBY Warby Parker Inc. compare | $7.5M |
| STAA STAAR Surgical Company compare | $530.0K |
| PLSE Pulse Biosciences, Inc compare | −$83.8M |
| XRAY DENTSPLY SIRONA Inc. compare | −$122.0M |
| AZTA Azenta, Inc. compare | −$122.9M |
| KMTS Kestra Medical Technologies, Ltd. compare | −$149.9M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on LMAT
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement